Astra Tech buys Atlantis
This article was originally published in The Gray Sheet
Executive Summary
Dental implant maker Atlantis Components is being acquired for $71 million by Swedish dental implant firm Astra Tech, a unit of AstraZeneca, announced Sept. 27. The purchase of Cambridge, Mass.-based Atlantis includes advanced digital CAD/CAM computer-aided design/computer-aided manufacturing technology that will help Astra Tech tailor implant abutments to individual patient requirements. The deal also boosts Astra Tech's North American presence, and adds Atlantis' $25 million in sales forecasted for 2008. Meanwhile, Atlantis' dental implant offerings will gain expanded market penetration. Astra Tech, which generated 2006 revenue of $414 million, says it has been able to grow at a 40%-plus rate over the past few years while the global dental implant market has expanded at a 20% rate
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.